CSTL
Castle Biosciences Inc
35.20$
+0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.5% | +10.4% | +19.2% | -1.4% | +0.6% | +1.9% | -2.0% | -3.6% | +4.8% | -3.8% | +23.7% | – | |
| – | +9.8% | +11.8% | +4.5% | +7.5% | +3.7% | +1.2% | +7.6% | +6.1% | -2.1% | +12.1% | +15.4% | – | |
| – | +7.0% | +10.0% | +22.7% | -3.2% | -0.1% | +2.1% | -4.2% | -6.2% | +6.8% | -8.1% | +26.4% | – | |
| – | +0.5% | +6.3% | +2.4% | -12.8% | -5.2% | +7.8% | +1.6% | +1.4% | +4.3% | +6.8% | +0.8% | – | |
| – | +6.2% | +4.8% | +2.6% | +12.2% | -5.4% | +11.6% | +5.2% | +0.8% | +0.9% | +2.3% | +5.6% | – | |
| – | -0.8% | +8.8% | +4.5% | -3.5% | +1.5% | +50.6% | -26.8% | -2.3% | +1.9% | +12.5% | +1.7% | – | |
| – | – | – | – | +1.3% | -20.3% | -789.6% | – | – | – | – | – | – | |
| – | +0.0% | +600.0% | +1,828.6% | -25.6% | -54.2% | -81.5% | +23.5% | +14.3% | +0.0% | +458.3% | +44.0% | – | |
| – | – | – | – | +5.0% | -4.8% | -433.2% | – | – | – | – | – | – | |
| – | +21.9% | +15.4% | -2,397.8% | – | -128.4% | – | – | – | -432.2% | – | +239.4% | – | |
| – | – | – | – | -74.6% | +322.7% | -369.5% | – | -111.1% | – | – | – | – | |
| – | – | +26.3% | +1,229.9% | +4.5% | +14.3% | -74.5% | -6.2% | +4.9% | -68.5% | -1,052.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.